Your browser doesn't support javascript.
loading
Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.
Cerny-Reiterer, Sabine; Rabenhorst, Anja; Stefanzl, Gabriele; Herndlhofer, Susanne; Hoermann, Gregor; Müllauer, Leonhard; Baumgartner, Sigrid; Beham-Schmid, Christine; Sperr, Wolfgang R; Mannhalter, Christine; Sill, Heinz; Linkesch, Werner; Arock, Michel; Hartmann, Karin; Valent, Peter.
Afiliação
  • Cerny-Reiterer S; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria.
  • Rabenhorst A; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
  • Stefanzl G; Department of Dermatology, University of Cologne, Cologne, Germany.
  • Herndlhofer S; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
  • Hoermann G; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
  • Müllauer L; Department of Laboratory Medicine, Medical University of Vienna, Austria.
  • Baumgartner S; Department of Pathology, Medical University of Vienna, Austria.
  • Beham-Schmid C; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria.
  • Sperr WR; Institute of Pathology, Medical University of Graz, Austria.
  • Mannhalter C; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria.
  • Sill H; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
  • Linkesch W; Department of Laboratory Medicine, Medical University of Vienna, Austria.
  • Arock M; Department of Internal Medicine, Division of Hematology, Medical University of Graz, Austria.
  • Hartmann K; Department of Internal Medicine, Division of Hematology, Medical University of Graz, Austria.
  • Valent P; LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, Cachan, France.
Oncotarget ; 6(5): 3071-84, 2015 Feb 20.
Article em En | MEDLINE | ID: mdl-25605011
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas Proto-Oncogênicas c-kit / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Mastócitos / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas Proto-Oncogênicas c-kit / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Mastócitos / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article